- Exchange: NYSE MKT LLC
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
BioTime Inc+ Add to Watchlist
BTX:US4.2500 USD 0.0500 1.19%
As of 20:04:05 ET on 03/02/2015.
Company Profile for BioTime Inc (BTX)
BioTime, Inc. researches and develops synthetic solutions that can be used as blood plasma volume expanders, blood replacement solutions during hypothermic surgery, and organ preservation solutions. The Company also operates in regenerative medicine sector, where it develops stem cell related products and technology for diagnostic, therapeutic and research use.
Key Executives for BioTime Inc (BTX)
|Michael D WestChief Executive Officer||Aditya MohantyChief Operating Officer|
|Lesley A StolzExec VP:Corporate Development||Robert W PeabodySenior VP/CFO|